Back

The impact of pre-implantation hemodynamic parameters on mortality post-Heartmate 3 implantation: an in-depth analysis

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: LVADs - long term outcomes and maximisation of care Ventricular Assist Devices HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Dovydas Verikas

Lithuanian University of Health Sciences, Kaunas (Lithuania)

6 More presentations in this session

Presentation thumbnail
The effect of HeartMate 3 on quality of life in advanced heart failure: results from a cohort study using EQ-5D-5L
Doctor I. Santos (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
Impact of digoxin utilization on gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis
Doctor B. Pitta Gros (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Breaking barriers in heart failure: baseline characteristics and insights from ultra-long LVAD survivors on the STELLAR Register
Mr C. Velasquez-Silva (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
Myocardial interstitial fibrosis as a prognostic factor for right ventricular failure post left ventricular assist device implantation
Doctor M. Bonios (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Ultra-long LVAD recipients: a new heart failure phenotype?
Doctor W. Nielsen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
LVADs - long term outcomes and maximisation of care

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Unraveling mortality predictors in continuous flow left ventricular assist device implantation: an in-depth analysis
thumbnail
Congress Presentation
Do preoperative factors influence cardiopulmonary bypass time and outweigh postoperative care after HeartMate 3 implantation?
thumbnail
Congress Presentation
Comparative analysis of ischaemic and dilated cardiomyopathy patients undergoing heartmate 3 implantation: insights from a tertiary hospital cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources